Summary
The White House is withdrawing Heidi Overton’s nomination to lead the Food and Drug Administration because she lacks enough congressional support. The Trump administration will need to select another candidate; the FDA is currently led by acting Commissioner Kyle Diamantas.Key Facts
- President Donald Trump nominated Overton in August.
- Overton is a physician and deputy director of the White House Domestic Policy Council.
- Democrats opposed Overton’s nomination, and some Republican senators expressed doubts.
- Sen. Bill Cassidy, chair of the Senate HELP Committee, said he had strong concerns about Overton’s role in changes to childhood vaccine recommendations.
- The Senate HELP Committee had scheduled a vote on Overton’s nomination for Wednesday.
- The White House said Overton did not have enough support in Congress to advance her confirmation.
- Kyle Diamantas has served as acting FDA commissioner since Marty Makary resigned in May.